Richard Dobal

🚨 DR. WILLIAM MAKIS SAYS THIS IS THE MOST IMPORTANT IVERMECTIN DOSING GRAPH HE'S CREATED. Not a new chemotherapy drug. Not a breakthrough immunotherapy. Not a billion-dollar cancer treatment. Just one simple dosing strategy. According to Dr. William Makis, this is the dosing framework he believes everyone researching repurposed medicines for cancer should understand first. And it all starts with one number. 📌 1 mg/kg/day. Before explaining why, here's the dosing framework Dr. Makis discusses. 📊 The Four Ivermectin Dosing Ranges 🟢 Low Dose: ≤0.5 mg/kg/day Used for cancers in remission, strong family history, genetic predisposition, prophylaxis, and lower-dose protocols discussed in published case reports. 🟡 Medium Dose: 1.0 mg/kg/day Dr. Makis' recommended starting dose for most cancers. 🔵 High Dose: 2.0 mg/kg/day Discussed for very aggressive cancers, including leukaemia, pancreatic cancer, and some brain cancers. 🔴 Very High Dose: ≥2.5 mg/kg/day Discussed in selected reported cases involving extensive metastatic disease or extremely poor prognosis, where temporary visual side effects have also been reported. Now here's why Dr. Makis believes 1 mg/kg/day deserves the most attention. After reviewing laboratory research, published studies, and numerous case reports, he says this is the starting dose he recommends for most cancers. According to Dr. Makis, research has investigated Ivermectin across a surprisingly wide range of cancers, including: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Kidney (renal cell) cancer • Gastric cancer • Leukemia One exception stood out. Lymphoma. Dr. Makis says he has found very little published research involving Ivermectin and lymphoma. That doesn't mean it doesn't work. It simply means the evidence is currently limited. ❓What does 1 mg/kg/day actually look like? For someone weighing 60 kg (132 lbs)... That's approximately 60 mg of Ivermectin every day. Equivalent to: 💊 Five 12 mg tablets OR 💧 About 6 mL of liquid Ivermectin, roughly one teaspoon. According to Dr. Makis, that's where he recommends starting for many cancers. Can lower doses still have an effect? ✅ He believes they can. Dr. Makis discusses a published ovarian cancer case reported by Dr. Tess Lawrie. The dosing chart lists the patient as receiving 12 mg of Ivermectin per day. During his discussion, Dr. Makis explains that this was approximately 0.2 mg/kg/day, placing it within the chart's Low Dose (≤0.5 mg/kg/day) range. 📉 According to the case report, the patient's CA125 tumor marker reportedly fell from 288 to 22 after two months. That case is one reason Dr. Makis believes Ivermectin may have anticancer activity even at lower doses. However... He also believes the available evidence suggests the effect is dose dependent. In other words... Higher doses may produce greater effects, although more clinical research is needed. What about the most aggressive cancers? • Pancreatic cancer • Leukemia • Brain cancer For cancers like these, Dr. Makis discusses doses around 2 mg/kg/day in selected situations. He notes that Ivermectin crosses the blood-brain barrier, although not very efficiently, which is one reason he says higher doses may be considered for some brain cancers. He also discusses a case reported by Dr. Allan Landrito. According to Dr. Makis, a physician with terminal gallbladder cancer reportedly took 2 mg/kg/day for 14 months. He says her cancer eventually disappeared. She experienced temporary visual side effects that resolved after a few days. ❓How high have reported doses gone? According to Dr. Makis, he has seen reported doses as high as 2.5 mg/kg/day. He references patients treated by Dr. Shankara Chetty who reportedly used those doses without long-term side effects, although some experienced temporary visual disturbances that later resolved. One point Dr. Makis returns to repeatedly... Long-term use. He references the Castro study involving children with leukemia who reportedly received Ivermectin for six months without long-term side effects. He also discusses anecdotal reports of adults taking it daily for more than a year without long-term toxicity. So why aren't there larger cancer trials? Dr. Makis believes one of the biggest obstacles is economics. Because Ivermectin is an off-patent generic medicine, he argues there is little financial incentive to fund large clinical trials. Whether future research ultimately confirms or challenges these ideas remains to be seen. But Dr. Makis' message is remarkably simple. One graph. One dosing strategy. One starting point. 📌 1 mg/kg/day. Because the conversation isn't just about Ivermectin anymore. It's about whether repurposed drugs deserve the same level of scientific investigation as newer therapies. 🗨️ Do you think inexpensive repurposed medicines like Ivermectin deserve larger, well-designed clinical trials for cancer? 🔖 Save this post so you'll always have Dr. Makis' dosing framework handy, and repost it to help others discover the ongoing research into repurposed medicines. 💊 Looking for pharmaceutical grade Ivermectin, Fenbendazole, or Mebendazole? Choose @MedsOnTap. Trusted by thousands of customers worldwide. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #CancerCare #MedicalResearch #PancreaticCancer #MakisMD #MedsOnTap